“…One of the markers of cancer progression and other pathologies is the appearance or upregulation of several keratin genes, including K17, K19, K6/16, etc. Keratins are not only routinely used for cancer diagnostics, but are also applicable for the prediction of invasiveness and aggressiveness of the tumor cell [ 242 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 250 , 251 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 ]. Following the aberrant expression, the reorganization of the keratin cytoskeleton affects the cell motility, survival, and resistance to external factors, which results in tumor treatment responsiveness [ 260 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 ].…”